fluconazole has been researched along with Sexually Transmitted Diseases in 5 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Sexually Transmitted Diseases: Diseases due to or propagated by sexual contact.
Excerpt | Relevance | Reference |
---|---|---|
"The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes." | 8.12 | Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. ( Dunaiski, CM; Jung, H; Kock, MM; Peters, RPH, 2022) |
"The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes." | 4.12 | Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. ( Dunaiski, CM; Jung, H; Kock, MM; Peters, RPH, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Dunaiski, CM | 1 |
Kock, MM | 1 |
Jung, H | 1 |
Peters, RPH | 1 |
Sim, M | 1 |
Logan, S | 1 |
Goh, LH | 1 |
Maatouk, I | 1 |
Hajjar, MA | 1 |
Moutran, R | 1 |
Ono, F | 1 |
Yasumoto, S | 1 |
Ressel, GW | 1 |
1 review available for fluconazole and Sexually Transmitted Diseases
Article | Year |
---|---|
[Genital candidiasis].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Diagnosis, Differential; Dosage Form | 2009 |
4 other studies available for fluconazole and Sexually Transmitted Diseases
Article | Year |
---|---|
Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia.
Topics: Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Female; Fluconazole; Humans; Male; | 2022 |
Vaginal discharge: evaluation and management in primary care.
Topics: Anti-Infective Agents; Antifungal Agents; Female; Fluconazole; Humans; Metronidazole; Primary Health | 2020 |
Candida albicans and Streptococcus pyogenes balanitis: diabetes or STI?
Topics: Amoxicillin; Anti-Bacterial Agents; Antifungal Agents; Balanitis; Candida albicans; Candidiasis; Dia | 2015 |
CDC releases 2002 guidelines for treating STDs: Part I. Diseases characterized by vaginal discharge and PID.
Topics: Anti-Infective Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Metronidazole; Pelvic | 2002 |